Identifying risk for attrition during treatment for depression

Psychotherapy and Psychosomatics

Volumn 78, Issue 6, 2009, Pages 372-379

  Warden, Diane ^a   Trivedi, Madhukar H ^a   Wisniewski, Stephen R ^b   Lesser, Ira M ^c   Mitchell, Jeff ^d   Balasubramani, G K ^b   Fava, Maurizio ^e   Shores Wilson, Kathy ^a   Stegman, Diane ^a   Rush, A John ^a,f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Laureate Psychiatric Clinic and Hospital   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adherence; Antidepressant; Attitudes; Attrition; Depression

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ATTITUDE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 69749115055     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235977     Document Type: Article

References (46)

1. Bockting CL, ten Doesschate MC, Spijker J, Spinhoven P, Koeter MW, Schene AH: Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008;77:17-26.
2. Katon W, Von Korff M, Lin E, Bush T, Ormel J: Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76.
3. Maddox JC, Levi M, Thompson C: The compliance with antidepressants in general practice. J Psychopharmacol 1994;8:48-53.
4. Lin EH, Von Korff M, Katon W, Bush T, Simon GE, Walker E, Robinson P: The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995;33:67-74.
5. Machado M, Iskedjian M, Ruiz I, Einarson TR: Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 2006;22:1825-1837. (Pubitemid 44449239)
6. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B: Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002;288:1403-1409.
7. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132. (Pubitemid 28558286)
8. Demyttenaere K, Adelin A, Patrick M, Walthere D, Katrien DB, Michele S: Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol 2008;23:36-42. (Pubitemid 350294868)
9. Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH: What predicts attrition in second step medication treatments for depression? A STAR*D report. Int J Neuropsychopharmacol 2009;12:459-473.
10. Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB: Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry 2002;51:123-133. (Pubitemid 34127902)
11. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917. (Pubitemid 44807782)
12. Insel TR, Quirion R: Psychiatry as a clinical neuroscience discipline. http://www.nimh.nih.gov/about/director/publications/psychiatry-as-a- neuroscience-discipline.shtml (last updated:6-17-2008, accessed:6-13-2008).
13. Mant D: Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:743-746.
14. Aikens JE, Kroenke K, Swindle RW, Eckert GJ: Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry 2005;27:229-236. (Pubitemid 40898247)
15. Bultman DC, Svarstad BL: Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 2000;40:173-185.
16. Hunot VM, Horne R, Leese MN, Churchill RC: A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry 2007;9:91-99. (Pubitemid 46607462)
17. Lin EH, Von Korff M, Ludman EJ, Rutter C, Bush TM, Simon GE, Unutzer J, Walker E, Katon WJ: Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry 2003;25:303-310.
18. Leon AC, Demirtas H, Hedeker D: Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial. Clin Trials 2007;4:540-547. (Pubitemid 350189877)
19. Demirtas H, Schafer JL: On the performance of random-coefficient pattern-mixture models for non-ignorable drop-out. Stat Med 2003;22:2553-2575. (Pubitemid 36974580)
20. Vis PM, van Baardewijk M, Einarson TR: Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. Ann Pharmacother 2005;39:1798-1807.
21. Zimmerman M, Mattia JI: A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001;58:787-794. (Pubitemid 32717805)
22. Zimmerman M, Mattia JI: The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry 2001;42:175-189. (Pubitemid 32410920)
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, rev. Washington, American Psychiatric Press, 2000.
24. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40. (Pubitemid 43050100)
25. Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D, Ritz L, Luther JF, Stegman D, DeVeaugh-Geiss J, Howland R: Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology 2007;32:2479-2489. (Pubitemid 350126843)
26. Trivedi MH, Daly EJ: Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend 2007;88(suppl 2):S61-S71.
27. Rush AJ, Carmody TJ, Reimitz PE: The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000;9:45-59.
28. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583 (erratum p 585). (Pubitemid 37289444)
29. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34:73-82. (Pubitemid 38139442)
30. Levine J, Schooler NR: SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986;22:343-381. (Pubitemid 16043808)
31. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA: Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006;12:71-79.
32. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ: Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am 2003;26:457-494, x. (Pubitemid 36583573)
33. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G: Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials 2004;25:119-142. (Pubitemid 38230109)
34. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
35. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
36. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN: The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-163. (Pubitemid 36418272)
37. Demyttenaere K, Albert A, Mesters P, Dewe W, De Bruyckere K, Sangeleer M: What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors? J Clin Psychiatry 2005;66:859-863.
38. Sotsky S, Glass D, Shea M, Pilkonis P, Collins J, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J, Oliveri ME: Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991;148:997-1008.
39. Krell HV, Leuchter AF, Morgan MM, Cook IA, Abrams M: Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 2004;65:1174-1179.
40. Imber SD, Pilkonis PA, Sotsky SM, Elkin I, Watkins JT, Collins JF, Shea MT, Leber WR, Glass DR: Mode-specific effects among three treatments for depression. J Consult Clin Psychol 1990;58:352-359. (Pubitemid 20301170)
41. Enck P, Benedetti F, Schedlowski M: New insights into the placebo and nocebo responses. Neuron 2008;59:195-206. (Pubitemid 352033692)
42. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR: The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep 2007;9:449-459. (Pubitemid 350284935)
43. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, Robinson P, Russo J: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995;273:1026-1031.
44. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon G, Walker E: A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-932.
45. Katon W, Von Korff M, Lin E, Simon G, Walker E, Unutzer J, Bush T, Russo J, Ludman E: Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999;56:1109-1115.
46. Stiefel F, Zdrojewski C, Bel Hadj F, Boffa D, Dorogi Y, So A, Ruiz J, de Jonge P: Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial. Psychother Psychosom 2008;77:247-256.